Background: Cardiovascular disease (CVD) is an escalating global health crisis,
contributing significantly to worldwide mortality and morbidity. Dyslipidemia stands as a …

Vascular endothelial growth factor A (VEGFA) is among the most-significant stimulators of
angiogenesis. Its effect on cardiovascular diseases and on the variation of related risk …

Cardiovascular diseases (CVDs) are the leading cause of death worldwide. Currently,
cardiovascular disease risk algorithms play a role in primary prevention. However, this is …

Aims The vascular endothelial growth factor (VEGF) family is involved in pathophysiological
mechanisms underlying cardio vascular (CV) diseases. The aim of this study was to …

Rationale: Vascular endothelial growth factor (VEGF) affects angiogenesis, atherosclerosis,
and cancer. Although the heritability of circulating VEGF levels is high, little is known about …

Coronary artery disease (CAD), a leading cause of death worldwide, has a complex etiology
comprising both traditional risk factors (type 2 diabetes, dyslipidemia, arterial hypertension …

Aims The vascular endothelial growth factor (VEGF) family is involved in pathophysiological
mechanisms underlying cardiovascular (CV) diseases. The aim of this study was to …

Vascular endothelial growth factor (VEGF) is an angiogenic and neurotrophic factor,
secreted by endothelial cells, known to impact various physiological and disease processes …

Background Genome-wide association studies (GWAS) have identified common variants at
the Vascular-Endothelial-Growth-Factor (VEGF) gene locus, which appear to be associated …

Background: Estimating the genetic risk of coronary artery disease (CAD) is now possible by
aggregating data from genome-wide association studies (GWAS) into polygenic risk scores …